ischem
stroke
devast
major
caus
morbid
mortal
worldwid
date
clot
retriev
devic
andor
intraven
tissu
plasminogen
activ
tpa
approv
usfda
treatment
acut
ischem
stroke
therefor
urgent
need
develop
effect
treatment
stroke
limit
shortcom
broad
spectrum
applic
interferonbeta
endogen
cytokin
key
antiinflammatori
agent
contribut
toward
obviat
deleteri
stroke
outcom
therefor
explor
role
may
promis
altern
approach
stroke
intervent
futur
present
review
discuss
along
differ
mechanist
role
ischem
stroke
furthermor
therapeut
approach
target
inflammatori
cascad
therapi
may
help
improv
stroke
outcom
also
discuss
antiinflammatori
cytokin
stroke
cite
articl
wanv
kaur
h
sarmah
et
al
therapeut
spectrum
ischem
stroke
stroke
global
health
concern
lead
perman
disabl
approxim
survivor
weinstein
koerner
devast
complic
aris
either
sudden
loss
blood
suppli
brain
ischem
stroke
ruptur
blood
vessel
brain
hemorrhag
stroke
deb
sharma
hassan
stroke
lead
induct
inflammatori
cascad
via
migrat
activ
microglia
ischem
core
worsen
outcom
perera
et
al
narrow
therapeut
window
insuffici
recov
protect
die
neuron
certain
limit
current
treatment
strategi
stroke
urgent
need
altern
approach
fann
et
al
kaur
et
al
limit
improv
aggrav
inflammatori
condit
current
use
thrombolyt
agent
necessit
newer
treatment
option
stroke
carrol
known
immunomodulatori
antiinflammatori
properti
explor
improv
condit
stroke
dhibjalbut
mark
play
role
antiinflammatori
agent
sever
immun
cascad
significantli
help
obviat
neuroinflammatori
condit
central
nervou
system
improv
pathogenesi
mani
neurolog
condit
report
suggest
role
decreas
neuron
cell
death
increas
function
recoveri
attenu
inflamm
stroke
onset
kuo
et
al
interferon
ifn
signal
protein
belong
famili
cytokin
nallar
kalvakolanu
ifn
activ
engag
alter
cellular
immun
system
viral
infect
host
cell
fritsch
weichhart
ifn
gener
act
extracellular
biomolecul
via
stimul
tolllik
receptor
tlr
amplifi
antigen
present
specif
cell
act
paracrin
autocrin
mode
regul
acquir
innat
immun
via
stimul
intercellular
intracellular
network
provid
resist
certain
viral
infect
mainten
normal
cell
surviv
tumor
cell
death
le
genin
bain
hiscott
interferon
classifi
accord
structur
homolog
receptor
type
type
ii
iii
type
ifn
includ
alpha
beta
delta
epsilon
kappa
omega
typeii
ifn
includ
gamma
typeiii
also
known
ifnlambda
interferonlik
activ
kopitarjerala
wack
hartmann
typei
ifn
act
bind
interferon
alphareceptor
ifnar
ifnar
heterodimer
transmembran
receptor
consist
two
subunit
sheppard
et
al
bind
ifn
ifnar
lead
activ
receptorassoci
protein
tyrosin
kinas
janu
kinas
tyrosin
kinas
turn
phosphoryl
signal
transduc
activ
transcript
activ
stat
follow
dimer
transloc
nucleu
combin
ifnregulatori
factor
form
trimolecular
complex
call
ifnstimul
gene
factor
bind
dna
sequenc
known
ifnstimul
respons
element
directli
activ
transcript
isg
signal
decay
within
period
hour
stat
export
back
cytoplasm
next
signal
process
figur
type
ifn
exhibit
wide
breadth
biolog
activ
antivir
antiinflammatori
antiprolif
kuo
et
al
latter
occur
via
cytotox
stimul
numer
cell
immun
system
natur
killer
cell
monocyt
cell
macrophag
dendrit
cell
ifn
also
upregul
cell
surfac
express
major
histocompat
complex
mhc
antigen
f
g
u
r
e
interferon
signal
pathway
bind
ifn
ifnar
receptor
activ
receptorassoci
protein
tyrosin
kinas
janu
b
tyrosin
c
signal
pathway
trif
two
protein
tyrosin
kinas
start
phosphoryl
signal
transduc
activ
activ
dimer
transloc
nucleu
format
trimolecular
complex
togeth
ifnregulatori
ifnstimul
gene
bind
dna
sequenc
call
ifnstimul
respons
element
ifnstimul
respons
element
activ
transcript
isg
directli
regul
signal
ifn
within
hour
signal
decay
stat
return
cytoplasm
next
signal
pathway
tlr
mediat
activ
trifdepend
pathway
via
interferon
regulatori
factor
colour
figur
view
wileyonlinelibrarycom
tumorassoci
surfac
antigen
help
induct
activ
proapoptot
gene
protein
bak
bax
tnfrelat
apoptosisinduc
ligand
trail
caspas
well
repress
reduct
antiapoptot
gene
inhibitor
apoptosi
protein
iap
bcell
lymphoma
respons
cell
prolifer
differenti
antiangiogen
activ
pestka
ifn
recogn
deepli
implic
pathogenesi
sever
diseas
exampl
collagen
diseas
rheumatoid
arthriti
conigliaro
et
al
system
lupu
erythematosu
sle
gao
anolik
looney
multipl
sclerosi
rudick
goelz
insulindepend
diabet
mellitu
qaisar
jurczyk
wang
pancreat
cancer
booy
hofland
van
eijck
fulmin
hepat
borst
et
al
atherosclerosi
moss
ramji
allerg
diseas
gonzalesvan
horn
farrar
ifn
clinic
use
therapi
viral
infect
hepat
b
c
asselah
marcellin
jaeckel
et
al
differ
malign
baron
et
al
imanishi
broadli
express
cytokin
approv
us
fda
past
relapsingremit
multipl
sclerosi
rrm
treatment
decad
kuo
et
al
drive
innat
immun
act
respons
pathogen
attack
injuri
via
activ
proand
antiinflammatori
cytokin
current
research
conduct
find
protect
role
sever
diseas
ischem
stroke
subarachnoid
hemorrhag
coliti
colorect
cancer
kotred
thoma
gamero
kuo
et
al
tiebosch
et
al
along
condit
tabl
antiinflammatori
kuo
et
al
antivir
krau
oschmann
samuel
immuno
modulatori
kasper
reder
antiprolif
dierckx
et
al
antiangiogen
friedman
cell
differenti
krau
oschmann
see
tabl
neurodegener
mostli
trigger
numer
inflammatori
mediat
lead
neurolog
patholog
includ
ischem
stroke
zipp
akta
inflamm
initi
releas
variou
inflammatori
mediat
activ
intravascular
leukocyt
help
infiltr
immun
cell
cn
anrath
iadecola
kieseier
immun
cell
migrat
across
bloodbrain
barrier
bbb
caus
breakdown
bbb
due
releas
numer
cytotox
agent
like
cytokin
matrix
metalloproteinas
nitric
oxid
reactiv
oxygen
speci
ro
lead
demyelin
axon
injuri
common
outcom
neurodegener
kuo
et
al
although
damag
caus
neuron
repar
immunomodulatori
therapi
report
decreas
inflamm
markowitz
polypeptid
produc
fibroblast
attach
specif
receptor
initi
complex
transcript
reaction
produc
pharmacolog
respons
site
injuri
markowitz
report
help
suppress
antigen
present
decreas
cell
prolifer
alter
cytokin
matrix
metalloproteinas
express
kieseier
markowitz
help
elev
concentr
express
antiinflammatori
agent
downregul
proinflammatori
cytokin
express
kuo
et
al
system
applic
may
reduc
increas
cell
count
inflammatori
cell
across
bbb
help
rais
nerv
growth
factor
ngf
level
ultim
result
dramat
increas
surviv
neuron
kieseier
may
also
help
rais
bright
natur
killer
cell
count
cell
produc
antiinflammatori
mediat
effici
capac
mitig
neuron
inflamm
peripher
blood
circul
variou
mechanist
approach
manifest
clinic
relev
reduc
lesion
decreas
risk
sustain
disabl
progress
decreas
brain
atrophi
kieseier
cerebr
ischemia
respons
produc
variou
immun
cell
mediat
exacerb
ischem
brain
injuri
variou
inflammatori
mediat
certain
situat
may
induc
toler
cerebr
ischemia
mediat
like
proinflammatori
cytokin
exampl
interleukin
tumor
necrosi
factor
tnf
damageassoci
molecular
pattern
damp
respons
activ
intracellular
signal
pathway
mediat
stress
respons
anrath
iadecola
ligand
type
name
receptor
chain
receptor
chain
ta
b
l
e
clinic
trial
interferon
interferon
immun
cell
therapi
highli
explor
preclin
also
clinic
set
variou
acut
injuri
relat
cn
includ
stroke
bang
georg
steinberg
immunomodulatori
help
regul
function
immun
cell
ischem
stroke
gen
present
stimul
cell
jiang
et
al
cell
death
follow
brain
ischemia
mediat
divers
group
etiolog
sever
focal
hypoperfus
eventu
result
excitotox
oxid
damag
lakhan
kirchgessn
hofer
event
respons
caus
microvascular
injuri
bbb
dysfunct
elicit
inflamm
ischemia
event
kind
worsen
primari
injuri
may
result
sever
cerebr
damag
extent
perman
cerebr
damag
reli
upon
differ
factor
ischem
durat
infarct
volum
along
autorepair
capabl
brain
dirnagl
iadecola
moskowitz
lakhan
et
al
respons
inflammatori
cascad
worsen
cerebr
injuri
postischemia
interest
target
therapeut
inflamm
increas
time
strongli
involv
exacerb
neuron
outcom
jin
yang
li
report
postischemia
system
appli
help
attenu
brain
infarct
progress
veldhui
et
al
subacut
phase
ischemia
resid
microgli
cell
mg
peripher
inflammatori
cell
infiltr
surround
core
region
infarct
area
brain
lead
secondari
neurodegener
weinstein
et
al
onset
ischemia
mainli
link
extravas
plasmaderiv
protein
bioactiv
phospholipid
bbb
disrupt
prompt
resid
mg
activ
infiltr
ischem
site
multifari
event
lead
activ
proinflammatori
cytokin
like
chemokin
cc
motif
ligand
chemokin
cc
motif
ligand
endogen
releas
injuri
site
culmin
neuron
death
dene
thornton
rothwel
allan
weinstein
et
al
ischem
injuri
chemokin
induct
enhanc
peripher
immun
cell
recruit
ischem
brain
chemokin
includ
monocyt
chemoattract
macrophag
inflammatori
essenti
recruit
monocytesmacrophag
chemokin
cxc
motif
ligand
essenti
neutrophil
recruit
kuo
et
al
induc
greater
level
ischem
brain
hori
et
al
wolinski
glabinski
zaremba
ilkowski
losi
minami
et
al
report
chemokin
bind
respect
receptor
express
brain
endotheli
surfac
lead
dynam
reorgan
actin
cytoskeleton
structur
alter
tight
junction
tj
caus
gradual
morpholog
chang
character
upregul
vascular
permeabl
stamatov
keep
kunkel
andjelkov
upregul
increas
vascular
permeabl
lead
format
brain
edema
found
major
reason
death
sever
infarct
ayata
ropper
minami
katayama
satoh
figur
matrix
releas
throughout
cours
ischem
injuri
increas
bbb
permeabl
via
degrad
extracellular
matrix
ecm
tj
brain
endothelium
facilit
inflammatori
immun
cell
infiltr
cn
chaturvedi
kaczmarek
lakhan
et
al
scientist
report
signific
effect
product
chemokin
mg
major
produc
inflammatori
cytokin
implic
f
g
u
r
e
mechan
action
ischem
injuri
immun
cell
like
mast
cell
macrophag
neutrophil
circul
releas
inflammatori
cytokin
inflammatori
cytokin
includ
ischem
injuri
site
overexpress
inflammatori
cytokin
overexpress
inflammatori
cytokin
lead
cn
inflamm
increas
cn
inflamm
result
infarct
format
brain
help
suppress
overexpress
inflammatori
cytokin
ultim
help
reduc
brain
infarct
ischem
brain
b
ischem
injuri
ipsilater
side
hemispher
increas
express
specif
express
microgli
cell
mg
help
mg
regul
cortex
increas
result
transform
rest
mg
reactiv
mg
reactiv
mg
influenc
releas
inflammatori
cytokin
exampl
lead
cytotox
turn
result
infarct
format
brain
injuri
site
inhibit
upregul
express
cortex
ipsilater
side
reduc
mg
activ
ischem
brain
colour
figur
view
wileyonlinelibrarycom
mediat
neuroinflamm
kuo
et
al
found
ischem
brain
dramat
increas
express
ipsilater
part
contralater
part
brain
treatment
help
reduc
cerebr
ischem
injuri
follow
reperfus
mainli
respons
infiltr
peripher
immun
cell
consist
cell
neutrophil
monocytesmacrophag
result
secondari
brain
injuri
eventu
respons
increas
degre
brain
infarct
benaki
et
al
wang
tang
yenari
scientist
also
report
throughout
cours
ischem
injuri
signific
rise
variou
cell
count
includ
neutrophil
monocyt
macrophag
ipsilater
part
ischem
brain
addit
found
treatment
significantli
help
lower
level
cell
kuo
et
al
figur
per
previou
report
cell
cell
also
playa
pathogen
role
ischem
stroke
gelderblom
arunachalam
magnu
shichita
et
al
aris
number
cell
cell
ischem
brain
lead
f
g
u
r
e
mechan
action
ischem
injuri
follow
reperfus
within
hour
ischemia
upregul
adhes
molecul
express
eg
eselectin
brain
endotheli
surfac
upregul
adhes
molecul
increas
influx
inflammatori
cell
eg
monocyt
neutrophil
b
cell
cell
ischem
brain
caus
infarct
format
reduc
upregul
adhes
molecul
express
eg
eselectin
help
reduc
infarct
format
decreas
inflammatori
cell
influx
brain
b
ischem
injuri
rest
microgli
cell
activ
increas
releas
matrix
metalloproteinas
tumor
necrosi
factor
monocyt
chemoattract
interleukin
facilit
inflammatori
cellinfiltr
monocyt
neutrophil
b
cell
cell
injuri
site
brain
increas
infiltr
inflammatori
cell
compromis
bloodbrain
barrier
bbb
integr
lead
secondari
brain
injuri
respons
increas
infarct
area
brain
impair
ischemiainduc
chemokin
cc
motif
ligand
chemokin
cxc
motif
ligand
express
help
reduc
brain
infarct
c
ischem
injuri
follow
reperfus
reperfus
increas
peripher
immun
cell
infiltr
cell
brain
injuri
lead
bbb
compromis
lead
bbb
disrupt
secondari
brain
injuri
result
infarct
format
brain
lower
number
infiltr
cell
cell
ipsilater
side
brain
show
protect
role
ischem
stroke
decreas
bbb
disrupt
colour
figur
view
wileyonlinelibrarycom
bbb
breakdown
increas
infarct
size
associ
induct
treatment
reduc
cell
cell
number
decreas
infarct
size
treatment
suppress
infiltr
variou
peripher
immun
cell
like
neutrophil
macrophagesmonocyt
cell
cell
provid
protect
role
ischem
stroke
kuo
et
al
figur
ischemia
inflammatori
process
lead
migrat
peripher
blood
leukocyt
brain
parenchyma
regul
adhes
molecul
adhes
molecul
includ
eselectin
pselectin
express
activ
brain
endotheli
cell
surfac
upregul
ischemia
respons
facilit
influx
inflammatori
cell
confer
bbb
breakdown
report
suggest
within
hour
reperfus
middl
cerebr
arteri
occlusionreperfus
mcaor
model
rat
adhes
molecul
found
upregul
brain
endotheli
cell
kuo
et
al
lindsberg
carp
paetau
karjalainenlindsberg
kast
zhang
chopp
zhang
jiang
power
sinc
discoveri
ifn
ifn
progress
poorli
understood
antivir
substanc
fdaapprov
treatment
five
disord
baron
et
al
discuss
variou
mechan
therapeut
potenti
howev
certain
side
effect
limit
use
pestka
although
usual
safe
well
toler
caus
certain
advers
effect
ifn
caus
local
advers
event
system
advers
reaction
well
goebel
treatment
patient
exhibit
fatigu
myalgia
headach
malais
joint
pain
pestka
depress
report
patient
prior
psychiatr
histori
follow
therapi
fragoso
et
al
reduc
dose
elicit
sever
depress
alter
toler
result
discontinu
treatment
asni
de
la
garza
ii
studi
demonstr
endogen
molecul
like
melatonin
potent
antioxid
regul
circadian
rhythm
mayb
help
mitig
depress
symptom
associ
hansen
danielsen
hageman
rosenberg
also
report
therapi
combin
lmethyl
folat
sadenosyl
methionin
vari
degre
outcom
monotherapi
augment
therapi
depress
franscina
pinto
andrad
howev
till
date
studi
examin
therapeut
treatment
depress
disord
therefor
apprais
possibl
futur
studi
thu
therapi
may
serv
substanti
therapi
treatment
acut
ischem
stroke
side
effect
reduc
prevent
inflamm
immun
essenti
fundament
part
pathogenesi
initi
ischem
reperfus
injuri
inflammatori
cascad
respons
initi
earli
molecular
event
caus
due
blood
vessel
occlus
culmin
brain
invas
variou
inflammatori
cell
cn
inflamm
cytotox
bbb
disrupt
peripher
immun
cell
infiltr
injuri
site
play
import
role
secondari
brain
injuri
lead
increas
brain
infarct
may
play
protect
multiphas
role
ischem
stroke
review
focus
neuroprotect
role
ischem
stroke
grow
bodi
evid
indic
inflammatori
mediat
predominantli
deleteri
primari
phase
ischem
stroke
may
promis
treatment
option
ischem
stroke
may
salutari
futur
adjuv
therapi
preclin
find
enter
clinic
level
therapeut
agent
ischem
stroke
howev
substanti
find
requir
carri
futur
better
understand
ischem
stroke
relat
cn
inflamm
cytotox
bbb
dysfunct
therapeut
potenti
ischem
stroke
author
also
want
express
thank
boston
children
hospit
harvard
medic
school
boston
usa
director
niper
ahmedabad
provid
necessari
support
author
conflict
interest
declar
